From Indigenous to FDA

A global episode, with Dr. Jahan Marcu in NYC, Dr. Nigam B Arora in the San Francisco, Sarah Russo in Spain, Sara Jane Ward in Philadelphia, and Joseph Mays in Washington DC. The group discusses our modern myths about the ancient use of psychedelics. Followed by discussions about the implications of a former FDA official joining a major psychedelics company, and water use research on cannabis. For the peer reviewed section of the show the group discusses the psilocybin research pipeline and the impact of cannabis use on male sexual function.Today’s game is a classic psychedelic whodunit, called Name that Drug, where we describe a case report and guess which substance is the culprit. 

Thanks to this episode’s sponsor Berkeley Patients Group!

Episode’s Group:

Jahan Marcu, PhD (moderator)

Joseph Mays

Sarah Russo

Sara Jane Ward, PhD

Nigam B. Arora, PhD

News and Popular Literature Links: 

How Common was Psychedelic use in Ingenious Cultures vs Ancient Societies (non-indegnenous)? (2:43)

Former FDA-er Joins Cybin (15:10)

Cannabis Farms not as Thirsty as Previously Thought (28:00)

Rapid Fire Science Study Links:

The Therapeutic Potential of Psilocybin (48:35)

The Impact of Cannabis Use on Male Sexual Function: A 10-year, single-center experience (1:11:00)

Today’s Game:

Name that Drug! Dr. Marcu reads a case report and the audience tries to guess the substance. A classic psychoactive whodunnit. Was it cannabis? Was it opioids? Was it a psychedelic compound? Test your critical thinking ability with this segment.

Credits:

Podcast editing by Joe Leonardo, Podcast mixing and mastering by Dylan Agajanian, Cover art by Selina Lee, Intro music by Buddha by Kontekst, Transition music by K. LOUK. Outro music by Bensounds. Special thanks to Julian Amkraut for supporting this episode.